Zinc: An underappreciated modulatory factor of brain function

Biochemical Pharmacology

Volumn 91, Issue 4, 2014, Pages 426-435

  Marger, L ^a   Schubert, C R ^b   Bertrand, D ^a  

^a HiQScreen   (Switzerland)

^b PFIZER INC   (United States)

Author keywords

Brain function; Ion channels; Neurotransmission; Transporters; Zinc

Indexed keywords

LIGAND GATED ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ZINC; ZINC TRANSPORTER;

ACRODERMATITIS ENTEROPATHICA; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; EPILEPSY; EXTRACELLULAR SPACE; GENETIC ASSOCIATION; GENETIC TRAIT; HUMAN; LIGAND BINDING; LONG TERM POTENTIATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; SCHIZOPHRENIA; SITE DIRECTED MUTAGENESIS; STOICHIOMETRY; SYNAPSE VESICLE; ZINC DEFICIENCY; ZINC HOMEOSTASIS; BRAIN; DOSE RESPONSE; DRUG EFFECTS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; PHYSIOLOGY; SYNAPTIC TRANSMISSION;

BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SYNAPTIC TRANSMISSION; ZINC;

EID: 84921692988     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2014.08.002     Document Type: Note

References (130)

1. Klug A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu Rev Biochem 2010;79:213-31.
2. Wende G. Epidermolysis bullosa hereditaria. J Cutan Dis 1902;20.
3. Ackland ML, Michalczyk A. Zinc deficiency and its inherited disorders - a review. Genes Nutr 2006;1:41-9.
4. King JC, Shames DM, Woodhouse LR. Zinc homeostasis in humans. J Nutr 2000;130:1360S-6S.
5. Plum LM, Rink L, Haase H. The essential toxin: impact of zinc on human health. Int J Environ Res Public Health 2010;7:1342-65.
6. Swardfager W, Herrmann N, Mazereeuw G, Goldberger K, Harimoto T, Lanctôt KL. Zinc in depression: a meta-analysis. Biol Psychiatry 2013;74:872-8.
7. Rembach A, Hare DJ, Doecke JD, Burnham SC, Volitakis I, Fowler CJ, et al. Decreased serum zinc is an effect of ageing and not Alzheimer's disease. Metallomics 2014.
8. Palmiter RD, Findley SD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J 1995;14:639-49.
9. Liuzzi JP, Blanchard RK, Cousins RJ. Differential regulation of zinc transporter 1, 2, and 4 mRNA expression by dietary zinc in rats. J Nutr 2001;131:46-52.
10. Guerinot ML. The ZIP family of metal transporters. Biochim Biophys Acta 2000;1465:190-8.
11. Liuzzi JP, Cousins RJ. Mammalian zinc transporters. Annu Rev Nutr 2004;24:151-72.
12. Kim AM, Vogt S, O'Halloran TV, Woodruff TK. Zinc availability regulates exit from meiosis in maturing mammalian oocytes. Nat Chem Biol 2010;6:674-81.
13. Ghavami-Maibodi SZ, Collipp PJ, Castro-Magana M, Stewart C, Chen SY. Effect of oral zinc supplements on growth, hormonal levels, and zinc in healthy short children. Ann Nutr Metab 1983;27:214-9.
14. Frederickson CJ, Giblin LJ, Krezel A, McAdoo DJ, Mueller RN, Muelle RN, et al. Concentrations of extracellular free zinc (pZn)e in the central nervous system during simple anesthetization, ischemia and reperfusion. Exp Neurol 2006;198:285-93.
15. Kay AR. Evidence for chelatable zinc in the extracellular space of the hippo-campus, but little evidence for synaptic release of Zn. J Neurosci 2003;23:6847-55.
16. Assaf SY, Chung SH. Release of endogenous Zn2+ from brain tissue during activity. Nature 1984;308:734-6.
17. Herd MB, Brown AR, Lambert JJ, Belelli D. Extrasynaptic GABA(A) receptors couple presynaptic activity to postsynaptic inhibition in the somatosensory thalamus. J Neurosci 2013;33:14850-68.
18. Pinheiro PS, Mulle C. Presynaptic glutamate receptors: physiological func-tions and mechanisms of action. Nat Rev Neurosci 2008;9:423-36.
19. Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron 2014;82:279-93.
20. Li Y, Hough CJ, Suh SW, Sarvey JM, Frederickson CJ. Rapid translocation of Zn(2+) from presynaptic terminals into postsynaptic hippocampal neurons after physiological stimulation. J Neurophysiol 2001;86:2597-604.
21. Vogt K, Mellor J, Tong G, Nicoll R. The actions of synaptically released zinc at hippocampal mossy fiber synapses. Neuron 2000;26:187-96.
22. Vergnano A, Rebola N, Savtchenko L, Pinheiro P, Casado M, Kieffer B, et al. Zinc dynamics and action at excitatory synapses. Neuron 2014;82:1101-14.
23. Yuan H, Hansen KB, Zhang J, Mark Pierson T, Markello TC, Fajardo KV, et al. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy. Nat Commun 2014;5:3251.
24. Zheng F, Erreger K, Low CM, Banke T, Lee CJ, Conn PJ, et al. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Nat Neurosci 2001;4:894-901.
25. Paoletti P, Ascher P, Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 1997;17:5711-25.
26. Low CM, Zheng F, Lyuboslavsky P, Traynelis SF. Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors. Proc Natl Acad Sci USA 2000;97:11062-67.
27. Hansen KB, Ogden KK, Yuan H, Traynelis SF. Distinct functional and phar-macological properties of triheteromeric GluN1/GluN2A/GluN2B NMDA receptors. Neuron 2014;81:1084-96.
28. Christine CW, Choi DW. Effect of zinc on NMDA receptor-mediated channel currents in cortical neurons. J Neurosci 1990;10:108-16.
29. Brejc K, van Dijk WJ, Klaassen RV, Schuurmans M, van Der Oost J, Smit AB, et al. Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature 2001;411:269-76.
30. Hsiao B, Dweck D, Luetje CW. Subunit-dependent modulation of neuronal nicotinic receptors by zinc. J Neurosci 2001;21:1848-56.
31. Moroni M, Vijayan R, Carbone A, Zwart R, Biggin PC, Bermudez I. Non-agonist-binding subunit interfaces confer distinct functional signatures to the alter-nate stoichiometries of the alpha4beta2 nicotinic receptor: an alpha4-alpha4 interface is required for Zn2+ potentiation. J Neurosci 2008;28:6884-94.
32. Harvey RJ, Thomas P, James CH, Wilderspin A, Smart TG. Identification of an inhibitory Zn2+ binding site on the human glycine receptor alpha1 subunit. J Physiol 1999;520(Pt 1):53-64.
33. McCracken LM, Blednov YA, Trudell JR, Benavidez JM, Betz H, Harris RA. Mutation of a zinc-binding residue in the glycine receptor a1 subunit changes ethanol sensitivity in vitro and alcohol consumption in vivo. J Pharmacol Exp Ther 2013;344:489-500.
34. Horenstein J, Akabas MH. Location of a high affinity Zn2+ binding site in the channel of alpha1beta1 gamma-aminobutyric acidA receptors. Mol Pharma-col 1998;53:870-7.
35. Corringer PJ, Bertrand S, Galzi JL, Devillers-Thiéry A, Changeux JP, Bertrand D. Mutational analysis of the charge selectivity filter of the [alpha] 7 nicotinic acetylcholine receptor. Neuron 1999;22:831-43.
36. Gill CH, Peters JA, Lambert JJ. An electrophysiological investigation of the properties of a murine recombinant 5-HT3 receptor stably expressed in HEK 293 cells. Br J Pharmacol 1995;114:1211-21.
37. Nagaya N, Tittle RK, Saar N, Dellal SS, Hume RI. An intersubunit zinc binding site in rat P2X2 receptors. J Biol Chem 2005;280:25982-93.
38. Davies PA, Wang W, Hales TG, Kirkness EF. A novel class of ligand-gated ion channel is activated by Zn2+. J Biol Chem 2003;278:712-7.
39. Popovics P, Stewart AJ. GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol Life Sci 2011;68:85-95.
40. Hershfinkel M, Moran A, Grossman N, Sekler I. A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci USA 2001;98:11749-54.
41. Chorin E, Vinograd O, Fleidervish I, Gilad D, Herrmann S, Sekler I, et al. Upregulation of KCC2 activity by zinc-mediated neurotransmission via the mZnR/GPR39 receptor. J Neurosci 2011;31:12916-26.
42. Kovacs Z, Schacht T, Herrmann AK, Albrecht P, Lefkimmiatis K, Methner A. Protein kinase inhibitor beta enhances the constitutive activity of G-protein coupled zinc receptor GPR39. Biochem J 2014.
43. Lee JY, Cole TB, Palmiter RD, Koh JY. Accumulation of zinc in degenerating hippocampal neurons of ZnT3-null mice after seizures: evidence against synaptic vesicle origin. J Neurosci 2000;20:RC79.
44. Emmetsberger J, Mirrione MM, Zhou C, Fernandez-Monreal M, Siddiq MM, Ji K, et al. Tissue plasminogen activator alters intracellular sequestration of zinc through interaction with the transporter ZIP4. J Neurosci 2010;30:6538-47.
45. Kovacs G, Danko T, Bergeron MJ, Balazs B, Suzuki Y, Zsembery A, et al. Heavy metal cations permeate the TRPV6 epithelial cation channel. Cell Calcium 2011;49:43-55.
46. Bouron A, Oberwinkler J. Contribution of calcium-conducting channels to the transport of zinc ions. Pflugers Arch 2014;466:381-7.
47. Weiss JH. Ca permeable AMPA channels in diseases of the nervous system. Front Mol Neurosci 2011;4:42.
48. Watt NT, Taylor DR, Kerrigan TL, Griffiths HH, Rushworth JV, Whitehouse IJ, et al. Prion protein facilitates uptake of zinc into neuronal cells. Nat Commun 2012;3:1134.
49. Watt NT, Griffiths HH, Hooper NM. Neuronal zinc regulation and the prion protein. Prion 2013;7:203-8.
50. Colvin RA, Holmes WR, Fontaine CP, Maret W. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics 2010;2:306-17.
51. Krezel A, Maret W. Zinc-buffering capacity of a eukaryotic cell at physiologi-cal pZn. J Biol Inorg Chem 2006;11:1049-62.
52. Sensi SL, Yin HZ, Weiss JH. AMPA/kainate receptor-triggered Zn2+ entry into cortical neurons induces mitochondrial Zn2+ uptake and persistent mito-chondrial dysfunction. Eur J Neurosci 2000;12:3813-8.
53. Berg JM, Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996;271:1081-5.
54. Chowanadisai W, Kelleher SL, Lönnerdal B. Maternal zinc deficiency reduces NMDA receptor expression in neonatal rat brain, which persists into early adulthood. J Neurochem 2005;94:510-9.
55. Babb TL, Kupfer WR, Pretorius JK, Crandall PH, Levesque MF. Synaptic reorganization by mossy fibers in human epileptic fascia dentata. Neurosci-ence 1991;42:351-63.
56. Danscher G, Stoltenberg M. Zinc-specific autometallographic in vivo seleni-um methods: tracing of zinc-enriched (ZEN) terminals, ZEN pathways, and pools of zinc ions in a multitude of other ZEN cells. J Histochem Cytochem 2005;53:141-53.
57. Esqueda AC, López JA, Andreu-de-Riquer G, Alvarado-Monzón JC, Ratnakar J, Lubag AJ, et al. A new gadolinium-based MRI zinc sensor. J Am Chem Soc 2009;131:11387-91.
58. Ketterman JK, Li YV. Presynaptic evidence for zinc release at the mossy fiber synapse of rat hippocampus. J Neurosci Res 2008;86:422-34.
59. Paoletti P, Vergnano AM, Barbour B, Casado M. Zinc at glutamatergic synap-ses. Neuroscience 2009;158:126-36.
60. Frederickson CJ, Koh JY, Bush AI. The neurobiology of zinc in health and disease. Nat Rev Neurosci 2005;6:449-62.
61. Adlard PA, Parncutt JM, Finkelstein DI, Bush AI. Cognitive loss in zinc transporter-3 knock-out mice: a phenocopy for the synaptic and memory deficits of Alzheimer's disease? J Neurosci 2010;30:1631-6.
62. Sloviter RS, Zappone CA, Harvey BD, Frotscher M. Kainic acid-induced recur-rent mossy fiber innervation of dentate gyrus inhibitory interneurons: pos-sible anatomical substrate of granule cell hyper-inhibition in chronically epileptic rats. J Comp Neurol 2006;494:944-60.
63. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mecha-nisms and relevance to human temporal lobe epilepsy. Neuroscience 1985;14:375-403.
64. Sloviter RS. A simplified Timm stain procedure compatible with formalde-hyde fixation and routine paraffin embedding of rat brain. Brain Res Bull 1982;8:771-4.
65. Takeda A. Movement of zinc and its functional significance in the brain. Brain Res Brain Res Rev 2000;34:137-48.
66. Pan E, Zhang XA, Huang Z, Krezel A, Zhao M, Tinberg CE, et al. Vesicular zinc promotes presynaptic and inhibits postsynaptic long-term potentiation of mossy fiber-CA3 synapse. Neuron 2011;71:1116-26.
67. Takeda A, Fujii H, Minamino T, Tamano H. Intracellular Zn(2+) signaling in cognition. J Neurosci Res 2014.
68. McCord MC, Aizenman E. The role of intracellular zinc release in aging, oxidative stress, and Alzheimer's disease. Front Aging Neurosci 2014;6:77.
69. Wong BX, Hung YH, Bush AI, Duce JA. Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology. Front Aging Neurosci 2014;6:91.
70. Bjorklund NL, Sadagoparamanujam VM, Taglialatela G. Selective, quantita-tive measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients. J Neurosci Methods 2012;203:146-51.
71. Schizophrenia Working Group of the Psychiatric Genomics. Consortium biological insights from 108 schizophrenia-associated genetic loci. Nature 2014;511:421-7.
72. Lemke JR, Lal D, Reinthaler EM, Steiner I, Nothnagel M, Alber M, et al. Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes. Nat Genet 2013;45:1067-72.
73. Moynahan EJ. Letter: acrodermatitis enteropathica: a lethal inherited human zinc-deficiency disorder. Lancet 1974;2:399-400.
74. Wang K, Pugh EW, Griffen S, Doheny KF, Mostafa WZ, al-Aboosi MM, et al. Homozygosity mapping places the acrodermatitis enteropathica gene on chromosomal region 8q24. 3. Am J Hum Genet 2001;68:1055-60.
75. Chowanadisai W, Lönnerdal B, Kelleher SL. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J Biol Chem 2006;281:39699-707.
76. Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-6.
77. Kirchhoff K, Machicao F, Haupt A, Schäfer SA, Tschritter O, Staiger H, et al. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008;51:597-601.
78. Flannick J, Thorleifsson G, Beer NL, Jacobs SB, Grarup N, Burtt NP, et al. Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. Nat Genet 2014;46:357-63.
79. Cyrus SHH, Melvyn WBZ, Anselm M, Roger CMH. Metabolic syndrome in psychiatry: advances in understanding and management. Adv Psychiatr Treat 2014;20:101-12.
80. Tuschl K, Clayton PT, Gospe SM, Gulab S, Ibrahim S, Singhi P, et al. Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am J Hum Genet 2012;90:457-66.
81. Quadri M, Federico A, Zhao T, Breedveld GJ, Battisti C, Delnooz C, et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hyperman-ganesemia, polycythemia, and chronic liver disease. Am J Hum Genet 2012;90:467-77.
82. Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013;45:1274-83.
83. Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovas-cular disease risk. Nature 2011;478:103-9.
84. Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-48.
85. Nebert DW, Gálvez-Peralta M, Hay EB, Li H, Johansson E, Yin C, et al. ZIP14 and ZIP8 zinc/bicarbonate symporters in Xenopus oocytes: characterization of metal uptake and inhibition. Metallomics 2012;4:1218-25.
86. Fukada T, Civic N, Furuichi T, Shimoda S, Mishima K, Higashiyama H, et al. The zinc transporter SLC39A13/ZIP13 is required for connective tissue develop-ment; its involvement in BMP/TGF-beta signaling pathways. PLoS ONE 2008;3:e3642.
87. O'Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet 2011;43:585-9.
88. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A, et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012;485:242-5.
89. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, et al. Individual common variants exert weak effects on the risk for autism spectrum dis-orderspi. Hum Mol Genet 2012;21:4781-92.
90. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011;476:214-9.
91. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, Heilbut A, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 2012;149:525-37.
92. Hess JL, Glatt SJ. How might ZNF804A variants influence risk for schizophre-nia and bipolar disorder? A literature review, synthesis, and bioinformatic analysis. Am J Med Genet B Neuropsychiatr Genet 2014;165:28-40.
93. Traynelis SF, Burgess MF, Zheng F, Lyuboslavsky P, Powers JL. Control of voltage-independent zinc inhibition of NMDA receptors by the NR1 subunit. J Neurosci 1998;18:6163-75.
94. Veran J, Kumar J, Pinheiro P, Athané A, Mayer M, Perrais D, et al. Zinc potentiates GluK3 glutamate receptor function by stabilizing the ligand binding domain dimer interface. Neuron 2012;76:565-78.
95. Hosie AM, Dunne EL, Harvey RJ, Smart TG. Zinc-mediated inhibition of GABA(A) receptors: discrete binding sites underlie subtype specificity. Nat Neurosci 2003;6:362-9.
96. Dunne EL, Hosie AM, Wooltorton JR, Duguid IC, Harvey K, Moss SJ, et al. An N-terminal histidine regulates Zn(2+) inhibition on the murine GABA(A) recep-tor beta3 subunit. Br J Pharmacol 2002;137:29-38.
97. Hadley SH, Amin J. Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities. J Physiol 2007;581:1001-18.
98. Barberis A, Cherubini E, Mozrzymas JW. Zinc inhibits miniature GABAergic currents by allosteric modulation of GABAA receptor gating. J Neurosci 2000;20:8618-27.
99. Laube B, Kuhse J, Rundström N, Kirsch J, Schmieden V, Betz H. Modulation by zinc ions of native rat and recombinant human inhibitory glycine receptors. J Physiol 1995;483(Pt 3):613-9.
100. Hsiao B, Mihalak KB, Repicky SE, Everhart D, Mederos AH, Malhotra A, et al. Determinants of zinc potentiation on the alpha4 subunit of neuronal nico-tinic receptors. Mol Pharmacol 2006;69:27-36.
101. Browne LE, North RA. P2X receptor intermediate activation states have altered nucleotide selectivity. J Neurosci 2013;33:14801-08.
102. Acuña-Castillo C, Morales B, Huidobro-Toro JP. Zinc and copper modulate differentially the P2X4 receptor. J Neurochem 2000;74:1529-37.
103. Wildman SS, King BF, Burnstock G. Modulatory activity of extracellular H+ and Zn2+ on ATP-responses at rP2X1 and rP2X3 receptors. Br J Pharmacol 1999;128:486-92.
104. Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, et al. Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmaco-logical properties compared with rat P2X(1). Mol Pharmacol 2002;62:957-66.
105. Chu XP, Wemmie JA, Wang WZ, Zhu XM, Saugstad JA, Price MP, et al. Subunit-dependent high-affinity zinc inhibition of acid-sensing ion channels. J Neu-rosci 2004;24:8678-89.
106. Hou S, Vigeland LE, Zhang G, Xu R, Li M, Heinemann SH, et al. Zn2+ activates large conductance Ca2+-activated K+ channel via an intracellular domain. J Biol Chem 2010;285:6434-42.
107. Prost AL, Bloc A, Hussy N, Derand R, Vivaudou M. Zinc is both an intracellular and extracellular regulator of KATP channel function. J Physiol 2004;559:157-67.
108. Gruss M, Mathie A, Lieb WR, Franks NP. The two-pore-domain K(+) channels TREK-1 and TASK-3 are differentially modulated by copper and zinc. Mol Pharmacol 2004;66:530-7.
109. Alvarez-Collazo J, Díaz-García CM, López-Medina AI, Vassort G, Alvarez JL. Zinc modulation of basal and b-adrenergically stimulated L-type Ca2+ cur-rent in rat ventricular cardiomyocytes: consequences in cardiac diseases. Pflugers Arch 2012;464:459-70.
110. Traboulsie A, Chemin J, Chevalier M, Quignard JF, Nargeot J, Lory P. Subunit-specific modulation of T-type calcium channels by zinc. J Physiol 2007;578:159-71.
111. Horning MS, Trombley PQ. Zinc and copper influence excitability of rat olfactory bulb neurons by multiple mechanisms. J Neurophysiol 2001;86:1652-60.
112. Huang L, Tepaamorndech S. The SLC30 family of zinc transporters-a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med 2013;34:548-60.
113. Lasry I, Seo YA, Ityel H, Shalva N, Pode-Shakked B, Glaser F, et al. A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency. J Biol Chem 2012;287:29348-61.
114. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, Willsey AJ, et al. De novo mutations revealed by whole-exome sequencing are strongly asso-ciated with autism. Nature 2012;485:237-41.
115. Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104:17040-45.
116. Noguchi E, Sakamoto H, Hirota T, Ochiai K, Imoto Y, Sakashita M, et al. Genome-wide association study identifies HLA-DP as a susceptibility gene for pediatric asthma in Asian populations. PLoS Genet 2011;7:e1002170.
117. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105-16.
118. Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-69.
119. Strawbridge RJ, Dupuis J, Prokopenko I, Barker A, Ahlqvist E, Rybin D, et al. Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 2011;60:2624-34.
120. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, Welch RP, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 2010;42:579-89.
121. Takeuchi F, Serizawa M, Yamamoto K, Fujisawa T, Nakashima E, Ohnaka K, et al. Confirmation of multiple risk loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 2009;58:1690-9.
122. Heid IM, Jackson AU, Randall JC, Winkler TW, Qi L, Steinthorsdottir V, et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010;42:949-60.
123. Randall JC, Winkler TW, Kutalik Z, Berndt SI, Jackson AU, Monda KL, et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet 2013;9:e1003500.
124. Lango Allen H, Estrada K, Lettre G, Berndt SI, Weedon MN, Rivadeneira F, et al. Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 2010;467:832-8.
125. Jeong J, Eide DJ. The SLC39 family of zinc transporters. Mol Aspects Med 2013;34:612-9.
126. Küry S, Dréno B, Bézieau S, Giraudet S, Kharfi M, Kamoun R, et al. Identifica-tion of SLC39A4, a gene involved in acrodermatitis enteropathica. Nat Genet 2002;31:239-40.
127. Schmitt S, Küry S, Giraud M, Dréno B, Kharfi M, Bézieau S. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum Mutat 2009;30:926-33.
128. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-13.
129. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012;491:119-24.
130. Giunta C, Elçioglu NH, Albrecht B, Eich G, Chambaz C, Janecke AR, et al. Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome-an auto-somal-recessive entity caused by mutations in the zinc transporter gene SLC39A13. Am J Hum Genet 2008;82:1290-305